Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Promising new live vaccine for equine influenza
The vaccine was created using reverse genetics, which means it can be updated to protect against emerging strains.
Scientists say progress is important for human and animal health

A new ‘live attenuated’ vaccine against equine influenza is showing promise, an initial trial suggests.

According to a paper published in the journal Virology, a single spray of the vaccine protected mice and horses against the H3N8 equine influenza virus, which is currently circulating.

Vaccinated horses reportedly showed none of the ‘tell-tale’ signs of influenza - which include nasal discharge, coughing and wheezing - after being exposed to a natural virus. In addition, scientists said no negative side effects were seen.

However, the study was small and involved only six horses, so plans are underway to conduct a larger study.

Given as a spray through the nose, the vaccine works by replicating and generating an immune response in the nose, where the virus first enters the body. Researchers from the University of Rochester Medical Center said the idea is to stop the virus taking hold in the horse’s respiratory tract.

The vaccine was created using a genetic engineering technique called reverse genetics, which offers a major advantage as it can be updated quickly and easily to protect against emerging strains. Traditional vaccines, on the other hand, take months to produce and do not allow the same flexibility.

Equine influenza is currently circulating in North America and Europe and is highly contagious, yet there has not been an updated vaccine for 25 years.

Associate professor Luis Martinez-Sobrido, said a new vaccine is not only important for animal health, but for humans too.

Animals such as horses, pigs and dogs can be infected with multiple influenza viruses and have the potential to act as ‘mixing vessels’, creating new strains that could infect people. While this has not yet occurred, it is possible, and these strains would be particularly dangerous as humans would have no pre-existing immunity.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.